Rankings
▼
Calendar
CERS Q3 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena
CERS
Cerus Corporation
$358M
Q3 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$46M
+15.7% YoY
Gross Profit
$26M
56.9% margin
Operating Income
-$961,000
-2.1% margin
Net Income
-$3M
-6.4% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+2.1%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$3M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$190M
Total Liabilities
$135M
Stockholders' Equity
$53M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$40M
+15.7%
Gross Profit
$26M
$22M
+20.1%
Operating Income
-$961,000
-$5M
+81.7%
Net Income
-$3M
-$7M
+59.6%
Revenue Segments
Product
$46M
91%
Government Contract
$5M
9%
Geographic Segments
North America
$32M
68%
Europe Middle East And Africa
$14M
30%
Other
$696,000
2%
← FY 2024
All Quarters
Q4 2024 →